Basal cells are stem/progenitor cells that maintain airway homeostasis, enact repair following epithelial injury and are a candidate cell-of-origin for lung squamous cell carcinoma (LUSC). Heterogeneity of basal cells is recognized in terms of gene expression and differentiation capacity. In this Issue, Pagano and colleagues isolate a subset of immortalized basal cells that are characterized by high motility, suggesting that they might also be heterogeneous in their biophysical properties.
Abstract
Basal cells are stem/progenitor cells that maintain airway homeostasis, enact repair following epithelial injury and are a candidate cell-of-origin for lung squamous cell carcinoma (LUSC). Heterogeneity of basal cells is recognized in terms of gene expression and differentiation capacity. In this Issue, Pagano and colleagues isolate a subset of immortalized basal cells that are characterized by high motility, suggesting that they might also be heterogeneous in their biophysical properties.
Motility-selected cells displayed an increased ability to colonize the lung in vivo. The possible implications of these findings are discussed in terms of basal cell heterogeneity, epithelial cell migration and modelling of metastasis that occurs early in cancer evolution.
Background
The human upper airway epithelium is a pseudostratified barrier that protects the lungs from infection and inhaled particulate matter using the mucociliary escalator.
Broadly, this function is supported by three major cell types: mucosecretory cells, ciliated cells and basal progenitor cells that function to regenerate the differentiated luminal populations [1] . Malignant transformation of this epithelium leads to lung squamous cell carcinoma (LUSC), which accounts for approximately 35% of nonsmall cell lung cancers, occurs predominantly in the central airways and has a poor prognosis. LUSC tumors are thought to arise through a step-wise epithelial transformation involving squamous metaplasia, dysplasia and carcinoma-in-situ (CIS) before progression to invasive cancer. Increasingly, it is recognized that significant genetic diversity, the basis of tumor evolution, exists in these premalignant disease stages and even in normal epithelia. It is noteworthy that in LUSC not all pre-invasive lesions inevitably progress to malignancy and the genetic, cellular and epigenetic basis of these changes are areas of active investigation [2] . Indeed, in the murine trachea, Notch3 activation is a hallmark of parabasal cells that can then respond to Notch1/2 signaling to be become secretory precursors and ultimately mature ciliated or mucosecretory cells [5, 6] . Interestingly, Notch3 is expressed by human parabasal cells and is downregulated in areas of squamous metaplasia, suggesting that aberrant differentiation of parabasal cells might be relevant in pre-invasive lesion formation [6] . In injury models, further heterogeneity has been described among P63+ basal cells as these rapidly become dual-positive for P63 and either MYB or Notch2 intracellular domain (N2ICD) and these cells only give rise to ciliated or mucosecretory cells, respectively [7] . As such, different basal cell lineage trajectories might be relevant to homeostasis and injury repair.
However, despite these findings, little is known about basal cell heterogeneity assessed by measures other than differentiation capacity. As such, the suggestion that a subset of premalignant basal cells might be intrinsically migratory in nature is an exciting hypothesis.
Epithelial Cell Motility and Lung Cancer
That the motility phenotype described by Pagano et al. is cell intrinsic, i.e. retained over serial cultivation, is suggestive of a relevance to in vivo basal cell heterogeneity and airway cell migration but care must be taken in extrapolating these results due to the possibility of changes introduced by cell culture. Basal cells were immortalized using retroviruses carrying Cdk4 and hTERT [8] and it remains to be determined and frequently clonal relationships cannot be proven conclusively. In one human patient, spatially distinct pre-invasive CIS lesions appeared to be clonally related based on a common, rare P53 mutation [9] , so further studies to delineate the relationship between epithelial cell migration and field carcinogenesis are warranted.
Pre-clinical studies of metastasis tend to focus on very late stage disease by using cell lines with high mutational burden and extensive genomic rearrangement but recent evidence has called into question the hypotheses that individual cells from the primary tumor seed metastases and that seeding of metastases occurs only during the late stages of tumor evolution. As such, novel strategies such as those described 
Modelling Pre-Invasive Lung Squamous Cell Carcinoma
Overall, the lack of available model systems to study pre-invasive LUSC is a major limitation for the field: tumors from GEMMs typically do not share comparable mutation profiles with human disease and do not recapitulate the progressive nature of human lesions. A recent study investigated the role of SOX2 -a transcription factor located on chromosome 3q, which is amplified prior to LUSC invasion -in early LUSC using the same immortalized cell lines as those used by Pagano et al. [11] . Combined P53 knockdown and SOX2 overexpression lead to dysplastic transformation of organotypic cultures. In combination, these studies demonstrate significant recent progress in modelling key aspects of pre-invasive disease. To our knowledge, primary cell culture methods for expansion of CIS cells have yet to be described and so studies that manipulate immortalized normal airway basal cells to provide a platform amenable to testing much needed therapeutics for early intervention LUSC studies are a welcome advance.
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